Poststroke Spasticity Management

被引:138
作者
Francisco, Gerard E. [1 ,2 ,3 ]
McGuire, John R. [4 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA
[2] TIRR Mem Hermann, STAR Spast Treatment & Res Clin, Houston, TX 77030 USA
[3] TIRR Mem Hermann, UTHlth Motor Recovery Lab, Houston, TX 77030 USA
[4] Med Coll Wisconsin, Dept Phys Med & Rehabil Stroke Rehabil & Comprehe, Milwaukee, WI 53226 USA
关键词
muscle hypertonia; muscle spasticity; rehabilitation; stroke; care; upper motor neuron disease; TOXIN TYPE-A; UPPER-LIMB SPASTICITY; INTERNATIONAL CONSENSUS STATEMENT; INTRATHECAL BACLOFEN THERAPY; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; BOTULINUM-TOXIN; DOUBLE-BLIND; STROKE; REHABILITATION;
D O I
10.1161/STROKEAHA.111.639831
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:3132 / 3136
页数:5
相关论文
共 56 条
  • [1] The relation between Ashworth scores and neuromechanical measurements of spasticity following stroke
    Alibiglou, Laila
    Rymer, William Z.
    Harvey, Richard L.
    Mirbagheri, Mehdi M.
    [J]. JOURNAL OF NEUROENGINEERING AND REHABILITATION, 2008, 5 (1)
  • [2] A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke
    Bakheit, AMO
    Thilmann, AF
    Ward, AB
    Poewe, W
    Wissel, J
    Muller, J
    Benecke, R
    Collin, C
    Muller, F
    Ward, CD
    Neumann, C
    [J]. STROKE, 2000, 31 (10) : 2402 - 2406
  • [3] The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles
    Bakheit, AMO
    Fedorova, NV
    Skoromets, AA
    Timerbaeva, SL
    Bhakta, BB
    Coxon, L
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (11) : 1558 - 1561
  • [4] Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial
    Bhakta, BB
    Cozens, JA
    Chamberlain, MA
    Bamford, JM
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (02) : 217 - 221
  • [5] Reliability of measurements obtained with the Modified Ashworth Scale in the lower extremities of people with stroke
    Blackburn, M
    van Vliet, P
    Mockett, SP
    [J]. PHYSICAL THERAPY, 2002, 82 (01): : 25 - 34
  • [6] Time course of muscle atrophy and recovery following a phenol-induced nerve block
    BodineFowler, SC
    Allsing, S
    Botte, MJ
    [J]. MUSCLE & NERVE, 1996, 19 (04) : 497 - 504
  • [7] Treatment with botulinum toxin type B for upper-limb spasticity
    Brashear, A
    McAfee, AL
    Kuhn, ER
    Ambrosius, WT
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (01): : 103 - 107
  • [8] Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke
    Brashear, A
    Gordon, MF
    Elovic, E
    Kassicieh, VD
    Marciniak, C
    Lee, CH
    Jenkins, S
    Turkel, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) : 395 - 400
  • [9] A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients
    Burbaud, P
    Wiart, L
    Dubos, JL
    Gaujard, E
    Debelleix, X
    Joseph, PA
    Mazaux, JM
    Bioulac, B
    Barat, M
    Lagueny, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) : 265 - 269
  • [10] Does botulinum toxin improve the function of the patient with spasticity after stroke?
    Cardoso, Eduardo
    Pedreira, Glicia
    Prazeres, Antonio
    Ribeiro, Nildo
    Melo, Ailton
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (3A) : 592 - 595